Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ESLA Estrella Immunopharma

交易中 12-15 09:36:06 EST

1.73

+0.00

0.00%

最高1.73	最低1.73	成交量144.00
今开1.73	昨收1.73	日振幅0.00%
总市值6,533万	流通市值1,900万	总股本3,777万
成交额249.09	换手率0.00%	流通股本1,099万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":1.73,"timestamp":1765809098605,"preClose":1.73,"halted":0,"volume":144,"delay":0,"floatShares":10985451,"shares":37765589,"eps":-0.367652,"marketStatus":"交易中","change":0,"latestTime":"12-15 09:36:06 EST","open":1.73,"high":1.73,"low":1.73,"amount":249.0880032,"amplitude":0,"askPrice":1.73,"askSize":99,"bidPrice":1.63,"bidSize":453,"shortable":3,"etf":0,"ttmEps":-0.367652,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.73,"preHourTrading":{"tag":"盘前","latestPrice":1.65,"preClose":1.73,"latestTime":"08:24 EST","volume":4,"amount":6.6,"timestamp":1765805098570},"postHourTrading":{"tag":"盘后","latestPrice":1.73,"preClose":1.73,"latestTime":"16:20 EST","volume":4,"amount":6.92,"timestamp":1765574400220},"volumeRatio":0.053211},"requestUrl":"/m/hq/s/ESLA/wiki","defaultTab":"wiki","newsList":[{"id":"2588032226","title":"Estrella Immunopharma, Inc.盘中异动 早盘大幅跳水5.21%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588032226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588032226?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:51","pubTimestamp":1764600673,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日22时51分，Estrella Immunopharma, Inc.股票出现波动，股价急速下跌5.21%。截至发稿，该股报2.00美元/股，成交量2.5864万股，换手率0.07%，振幅9.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201225113a71d2844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201225113a71d2844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2586129096","title":"Estrella Immunopharma, Inc.盘中异动 早盘快速上涨6.93%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586129096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586129096?lang=zh_cn&edition=full","pubTime":"2025-11-26 22:34","pubTimestamp":1764167682,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日22时34分，Estrella Immunopharma, Inc.股票出现波动，股价急速上涨6.93%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Scisparc Ltd.、Quantum Biopharma Ltd.涨幅较大，Scisparc Ltd.、Kala Bio, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为1809.05%、154.82%、41.09%，振幅较大的相关个股有Quantum Biopharma Ltd.、Pasithea Therapeutics Corp.、Scisparc Ltd.，振幅分别为20.40%、10.89%、9.45%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126223442951bd857&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126223442951bd857&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2586781304","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨5.26%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586781304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586781304?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:52","pubTimestamp":1763999523,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时52分，Estrella Immunopharma, Inc.股票出现异动，股价快速上涨5.26%。截至发稿，该股报1.60美元/股，成交量2.171万股，换手率0.06%，振幅4.61%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124235203a70ea86a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124235203a70ea86a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2585711371","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨5.43%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585711371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585711371?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:36","pubTimestamp":1763649413,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日22时36分，Estrella Immunopharma, Inc.股票出现波动，股价急速拉升5.43%。截至发稿，该股报1.85美元/股，成交量9935股，换手率0.03%，振幅3.43%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120223653a4af7c96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120223653a4af7c96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2584963539","title":"Estrella Immunopharma, Inc.盘中异动 快速跳水6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584963539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584963539?lang=zh_cn&edition=full","pubTime":"2025-11-19 01:30","pubTimestamp":1763487003,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日01时30分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌6.18%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111901300397719f9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111901300397719f9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2581064165","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨7.15%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581064165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581064165?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:38","pubTimestamp":1762353485,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日22时38分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨7.15%。截至发稿，该股报2.45美元/股，成交量3.9399万股，换手率0.11%，振幅5.68%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511052238059755fcda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511052238059755fcda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"1164382933","title":"Estrella Immunopharma 完成剂量组后，DSMB将审查研究数据的安全性和有效性","url":"https://stock-news.laohu8.com/highlight/detail?id=1164382933","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164382933?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:10","pubTimestamp":1762175410,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma 完成剂量组后，DSMB将审查研究数据的安全性和有效性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"1155605883","title":"Estrella Immunopharma在Starlight-1试验中完成第二剂量组的评估，所有可评估患者均获得完全缓解","url":"https://stock-news.laohu8.com/highlight/detail?id=1155605883","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155605883?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:01","pubTimestamp":1762174878,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma在Starlight-1试验中完成第二剂量组的评估，所有可评估患者均获得完全缓解","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2572604405","title":"Estrella Immunopharma, Inc.盘中异动 急速拉升6.83%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572604405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572604405?lang=zh_cn&edition=full","pubTime":"2025-10-01 21:32","pubTimestamp":1759325538,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日21时32分，Estrella Immunopharma, Inc.股票出现波动，股价急速拉升6.83%。截至发稿，该股报1.23美元/股，成交量230股，换手率0.00%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001213218a4502d8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001213218a4502d8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2570866901","title":"Estrella Immunopharma, Inc.盘中异动 临近收盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570866901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570866901?lang=zh_cn&edition=full","pubTime":"2025-09-27 03:48","pubTimestamp":1758916115,"startTime":"0","endTime":"0","summary":"北京时间2025年09月27日03时48分，Estrella Immunopharma, Inc.股票出现异动，股价快速拉升5.22%。截至发稿，该股报1.21美元/股，成交量9.4518万股，换手率0.26%，振幅5.22%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927034835a446a484&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927034835a446a484&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2569332067","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨7.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569332067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569332067?lang=zh_cn&edition=full","pubTime":"2025-09-22 21:37","pubTimestamp":1758548220,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日21时37分，Estrella Immunopharma, Inc.股票出现波动，股价大幅上涨7.21%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Metsera, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Onconetix, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2271.51%、122.97%、38.26%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Onconetix, Inc.、Adverum Biotechnologies, Inc.，振幅分别为68.66%、22.86%、19.53%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922213700a72f87b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922213700a72f87b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2568431777","title":"Estrella Immunopharma, Inc.盘中异动 急速上涨5.36%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568431777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568431777?lang=zh_cn&edition=full","pubTime":"2025-09-17 03:30","pubTimestamp":1758051019,"startTime":"0","endTime":"0","summary":"北京时间2025年09月17日03时30分，Estrella Immunopharma, Inc.股票出现波动，股价快速拉升5.36%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509170330209796c1b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509170330209796c1b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2560438124","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨7.16%报0.985美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560438124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560438124?lang=zh_cn&edition=full","pubTime":"2025-08-20 02:41","pubTimestamp":1755628861,"startTime":"0","endTime":"0","summary":"北京时间2025年08月20日02时41分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨7.16%。截至发稿，该股报0.985美元/股，成交量591股，换手率0.00%，振幅4.02%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.97%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082002410197521bce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082002410197521bce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2558866168","title":"Estrella Immunopharma, Inc.盘中异动 急速上涨5.71%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558866168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558866168?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:22","pubTimestamp":1754925766,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时22分，Estrella Immunopharma, Inc.股票出现异动，股价急速上涨5.71%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5561.67%、490.85%、169.04%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232247a4823ecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232247a4823ecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2557313410","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨5.02%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557313410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557313410?lang=zh_cn&edition=full","pubTime":"2025-08-06 00:25","pubTimestamp":1754411132,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日00时25分，Estrella Immunopharma, Inc.股票出现波动，股价急速拉升5.02%。截至发稿，该股报0.870美元/股，成交量2168股，换手率0.01%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为3.18%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080600253294d1a0af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080600253294d1a0af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2556380934","title":"Estrella Immunopharma, Inc.盘中异动 股价大跌5.87%报0.805美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556380934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556380934?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:32","pubTimestamp":1754317961,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时32分，Estrella Immunopharma, Inc.股票出现异动，股价大幅跳水5.87%。截至发稿，该股报0.805美元/股，成交量2680股，换手率0.01%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804223241a6d29adb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804223241a6d29adb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2556837183","title":"Estrella Immunopharma, Inc.盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556837183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556837183?lang=zh_cn&edition=full","pubTime":"2025-08-01 00:42","pubTimestamp":1753980146,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日00时42分，Estrella Immunopharma, Inc.股票出现异动，股价大幅跳水5.14%。截至发稿，该股报0.830美元/股，成交量3145股，换手率0.01%，振幅4.29%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为2.91%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。Estrella 的使命是利用人类免疫系统的进化力量来改变癌症和自身免疫性疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801004227a6cc0cef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801004227a6cc0cef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2555040059","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大跌6.99%报0.874美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555040059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555040059?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:30","pubTimestamp":1753885806,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时30分，Estrella Immunopharma, Inc.股票出现异动，股价急速下跌6.99%。截至发稿，该股报0.874美元/股，成交量2215股，换手率0.01%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730223006a46bc8d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730223006a46bc8d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2551198097","title":"Estrella Immunopharma, Inc.盘中异动 早盘快速跳水5.08%报0.840美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551198097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551198097?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:16","pubTimestamp":1752589009,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时16分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌5.08%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715221649a6ab689d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715221649a6ab689d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2551184131","title":"Estrella Immunopharma, Inc.盘中异动 早盘大幅下跌7.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551184131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551184131?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:52","pubTimestamp":1752501147,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时52分，Estrella Immunopharma, Inc.股票出现异动，股价快速下挫7.86%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1741.19%、624.89%、471.59%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Biomx Inc.，振幅分别为163.93%、115.31%、87.78%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714215227954230d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714215227954230d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.estrellabio.com","stockEarnings":[{"period":"1week","weight":-0.1307},{"period":"1month","weight":-0.1762},{"period":"3month","weight":0.6476},{"period":"6month","weight":0.8021},{"period":"1year","weight":0.4009},{"period":"ytd","weight":0.4417}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Estrella Immunopharma, Inc.于2021年1月6日在特拉华州注册成立。该公司是一家临床前阶段的生物制药公司，开发CD19和CD22靶向ARTEMIS T细胞疗法，有能力应对血癌和实体瘤患者的治疗挑战。该公司的使命是利用人类免疫系统的进化力量，改变癌症患者的生活。为了完成这一使命，该公司的主要候选产品EB103利用Eureka的ARTEMIS技术来靶向CD19，一种在几乎所有B细胞白血病和淋巴瘤表面表达的蛋白质。该公司也在开发EB104，它还利用Eureka的ARTEMIS技术，不仅针对CD19，还针对CD22，一种与CD19一样在大多数B细胞恶性肿瘤表面表达的蛋白质。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":-0.019009},{"month":2,"riseRate":0.5,"avgChangeRate":-0.025426},{"month":3,"riseRate":0.5,"avgChangeRate":0.026432},{"month":4,"riseRate":0.75,"avgChangeRate":0.006035},{"month":5,"riseRate":0.25,"avgChangeRate":-0.040145},{"month":6,"riseRate":0.5,"avgChangeRate":0.017516},{"month":7,"riseRate":0.5,"avgChangeRate":0.07367},{"month":8,"riseRate":0.25,"avgChangeRate":-0.054345},{"month":9,"riseRate":0.75,"avgChangeRate":0.07408},{"month":10,"riseRate":0.6,"avgChangeRate":-0.005756},{"month":11,"riseRate":0.8,"avgChangeRate":0.071826},{"month":12,"riseRate":0.2,"avgChangeRate":-0.093392}],"exchange":"NASDAQ","name":"Estrella Immunopharma","nameEN":"Estrella Immunopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Estrella Immunopharma,ESLA,Estrella Immunopharma股票,Estrella Immunopharma股票老虎,Estrella Immunopharma股票老虎国际,Estrella Immunopharma行情,Estrella Immunopharma股票行情,Estrella Immunopharma股价,Estrella Immunopharma股市,Estrella Immunopharma股票价格,Estrella Immunopharma股票交易,Estrella Immunopharma股票购买,Estrella Immunopharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}